Infective endocarditis complicated by shock: a systematic review and meta-analysis.

IF 4.2 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Roxana-Bianca Pîrîianu-Masgras, Alexandre Mebazaa, Gianluigi Savarese, Emanuel Stoica, Oliviana Geavlete, Andrew P Ambrosy, Elena-Laura Antohi, Mehmet Birhan Yilmaz, Razvan-Ilie Radu, Marianna Adamo, Beth A Davison, Jan Biegus, Gad Cotter, Javed Butler, Sean P Collins, Ovidiu Chioncel
{"title":"Infective endocarditis complicated by shock: a systematic review and meta-analysis.","authors":"Roxana-Bianca Pîrîianu-Masgras, Alexandre Mebazaa, Gianluigi Savarese, Emanuel Stoica, Oliviana Geavlete, Andrew P Ambrosy, Elena-Laura Antohi, Mehmet Birhan Yilmaz, Razvan-Ilie Radu, Marianna Adamo, Beth A Davison, Jan Biegus, Gad Cotter, Javed Butler, Sean P Collins, Ovidiu Chioncel","doi":"10.1007/s10741-025-10556-5","DOIUrl":null,"url":null,"abstract":"<p><p>Infective endocarditis (IE) complicated by septic or cardiogenic shock is linked to a marked increase in morbidity and mortality rates. This systematic review and meta-analysis sought to evaluate clinical outcomes, identify prognostic factors, and assess the effects of valve surgical intervention in patients with infective endocarditis complicated by shock. Systematic searches were performed in PubMed, Cochrane Library, and Google Scholar databases, following PRISMA and MOOSE guidelines. Included were observational studies published from January 2015 to May 2025 that reported on adult patients with infective endocarditis complicated by septic or cardiogenic shock. A random-effects model was utilized for data synthesis (restricted maximum likelihood with Hartung-Knapp adjustment), and meta-regression was conducted to assess sources of heterogeneity. Seven observational studies were included (n = 183-255,838). In-hospital mortality among patients with shock was 62.3% (95% CI 48.3-74.5%). Compared with IE without shock, the pooled odds ratio for in-hospital mortality (HK-REML) was 5.83 (95% CI 1.35-25.23; 95% prediction interval 0.26-129.69), with substantial heterogeneity (I<sup>2</sup> = 90.3%). Valve surgical intervention was associated with reduced mortality, particularly in cardiogenic shock. Staphylococcus aureus was the most common pathogen in available microbiological data. Shock was frequently accompanied by acute kidney injury, neurological complications, and multiorgan dysfunction. Infective endocarditis complicated by shock carries an extremely poor prognosis, with pooled mortality exceeding 60%. Prompt recognition of shock, timely initiation of appropriate antimicrobial therapy, hemodynamic stabilization, and early valve surgery are crucial to improve outcomes in this high-risk population. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD420250652570.</p>","PeriodicalId":12950,"journal":{"name":"Heart Failure Reviews","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Failure Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10741-025-10556-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Infective endocarditis (IE) complicated by septic or cardiogenic shock is linked to a marked increase in morbidity and mortality rates. This systematic review and meta-analysis sought to evaluate clinical outcomes, identify prognostic factors, and assess the effects of valve surgical intervention in patients with infective endocarditis complicated by shock. Systematic searches were performed in PubMed, Cochrane Library, and Google Scholar databases, following PRISMA and MOOSE guidelines. Included were observational studies published from January 2015 to May 2025 that reported on adult patients with infective endocarditis complicated by septic or cardiogenic shock. A random-effects model was utilized for data synthesis (restricted maximum likelihood with Hartung-Knapp adjustment), and meta-regression was conducted to assess sources of heterogeneity. Seven observational studies were included (n = 183-255,838). In-hospital mortality among patients with shock was 62.3% (95% CI 48.3-74.5%). Compared with IE without shock, the pooled odds ratio for in-hospital mortality (HK-REML) was 5.83 (95% CI 1.35-25.23; 95% prediction interval 0.26-129.69), with substantial heterogeneity (I2 = 90.3%). Valve surgical intervention was associated with reduced mortality, particularly in cardiogenic shock. Staphylococcus aureus was the most common pathogen in available microbiological data. Shock was frequently accompanied by acute kidney injury, neurological complications, and multiorgan dysfunction. Infective endocarditis complicated by shock carries an extremely poor prognosis, with pooled mortality exceeding 60%. Prompt recognition of shock, timely initiation of appropriate antimicrobial therapy, hemodynamic stabilization, and early valve surgery are crucial to improve outcomes in this high-risk population. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD420250652570.

感染性心内膜炎并发休克:一项系统回顾和荟萃分析。
感染性心内膜炎(IE)并发脓毒性或心源性休克与发病率和死亡率显著增加有关。本系统综述和荟萃分析旨在评估临床结果,确定预后因素,并评估瓣膜手术干预对感染性心内膜炎合并休克患者的影响。系统检索PubMed、Cochrane Library和谷歌Scholar数据库,遵循PRISMA和MOOSE指南。纳入了2015年1月至2025年5月发表的观察性研究,这些研究报告了感染性心内膜炎并发脓毒性或心源性休克的成年患者。随机效应模型用于数据综合(Hartung-Knapp调整的限制最大似然),并进行meta回归来评估异质性的来源。纳入7项观察性研究(n = 183-255,838)。休克患者的住院死亡率为62.3% (95% CI 48.3-74.5%)。与无休克的IE相比,住院死亡率(HK-REML)的合并优势比为5.83 (95% CI 1.35-25.23; 95%预测区间0.26-129.69),存在显著异质性(I2 = 90.3%)。瓣膜手术干预与死亡率降低有关,特别是心源性休克。在现有的微生物学资料中,金黄色葡萄球菌是最常见的病原体。休克常伴有急性肾损伤、神经系统并发症和多器官功能障碍。感染性心内膜炎合并休克预后极差,总死亡率超过60%。及时识别休克,及时开始适当的抗菌治疗,血流动力学稳定和早期瓣膜手术对改善这一高危人群的预后至关重要。系统评价注册:prospero: crd420250652570。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Heart Failure Reviews
Heart Failure Reviews 医学-心血管系统
CiteScore
10.40
自引率
2.20%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Heart Failure Reviews is an international journal which develops links between basic scientists and clinical investigators, creating a unique, interdisciplinary dialogue focused on heart failure, its pathogenesis and treatment. The journal accordingly publishes papers in both basic and clinical research fields. Topics covered include clinical and surgical approaches to therapy, basic pharmacology, biochemistry, molecular biology, pathology, and electrophysiology. The reviews are comprehensive, expanding the reader''s knowledge base and awareness of current research and new findings in this rapidly growing field of cardiovascular medicine. All reviews are thoroughly peer-reviewed before publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信